Manjusha Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.20 Cr
as on 17-12-2024
- Satisfied Charges ₹ 17.49 Cr
as on 17-12-2024
- Revenue 15.11%
(FY 2022)
- Profit 4.25%
(FY 2022)
- Ebitda 7.02%
(FY 2022)
- Net Worth 51.55%
(FY 2022)
- Total Assets -5.71%
(FY 2022)
About Manjusha Healthcare
The Corporate was formerly known as Dr Home Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹15.20 Cr. The company has closed loans amounting to ₹17.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Yakhmi and Roma Sachdeva serve as directors at the Company.
- CIN/LLPIN
U85110DL2008PTC178118
- Company No.
178118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Manjusha Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Yakhmi  | Director | 14-May-2008 | Current |
| Roma Sachdeva | Director | 14-May-2008 | Current |
Financial Performance and Corporate Structure Insights of Manjusha Healthcare.
Manjusha Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.11% increase. The company also saw a slight improvement in profitability, with a 4.25% increase in profit. The company's net worth Soared by an impressive increase of 51.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manjusha Healthcare?
In 2021, Manjusha Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jul 2022 | ₹15.20 Cr | Open |
Others Creation Date: 16 Jul 2020 | ₹2.49 Cr | Satisfied |
Others Creation Date: 31 May 2016 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Manjusha Healthcare?
Manjusha Healthcare has a workforce of 98 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manjusha Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manjusha Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
